Jiunn-chang Lin
TPQ 11260, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Machine-Learning Based Prognostic Model for Predicting Early Recurrence in HCC Patients After Hepatectomies: An Explainable AI Approach.
Journal: Journal of hepatocellular carcinoma
Published: April 19, 2026
LDN-57444 sensitizes hepatocellular carcinoma cells to sorafenib by promoting ferroptosis through histone deacetylase 2 (HDAC2) inhibition.
Journal: Biology direct
Published: December 03, 2025
Nedd4 family interacting protein 1 (NDFIP1) is a novel target of PF-429242 in promoting autophagy in hepatocellular carcinoma cells.
Journal: Biochemical and biophysical research communications
Published: August 06, 2025
Impact of Obesity on Colon/Liver Resection With Colorectal Liver Metastasis: Analysis of US Nationwide Inpatient Sample 2005-2020.
Journal: Clinical and translational gastroenterology
Published: December 23, 2024
The combination of PF-429242 and chloroquine triggers pH-dependent cell death in hepatocellular carcinoma cells.
Journal: International journal of medical sciences
Published: December 19, 2024
PF-429242 exhibits anticancer activity in hepatocellular carcinoma cells via FOXO1-dependent autophagic cell death and IGFBP1-dependent anti-survival signaling.
Journal: American journal of cancer research
Published: May 18, 2023
The online interactive visual learning improves learning effectiveness and satisfaction of physicians with postgraduate year during the COVID-19 pandemic in Taiwan.
Journal: BMC medical education
Published: May 10, 2023
Inhibition of CDK9 exhibits anticancer activity in hepatocellular carcinoma cells via targeting ribonucleotide reductase.
Journal: Toxicology and applied pharmacology
Published: February 23, 2023
Wasabi Component 6-(Methylsulfinyl)hexly Isothiocyanate and Derivatives Improve the Survival of Skin Allografts.
Journal: International journal of molecular sciences
Published: June 30, 2022
Bioinformatics Analysis Identifies Precision Treatment with Paclitaxel for Hepatocellular Carcinoma Patients Harboring Mutant TP53 or Wild-Type CTNNB1 Gene.
Journal: Journal of personalized medicine
Published: October 12, 2021
Last Updated: 09/26/2026